ASX - By Stock
|
MSB |
Re:
the shorts will bail with margin calling and announcements due
|
|
DeputyDawg
|
482 |
120K |
26 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
482
|
120K
|
26
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
DeputyDawg
|
10K |
3.0M |
56 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
56
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Partner with MSB for Imflammatory Bowel Disease?
|
|
DeputyDawg
|
4 |
1.5K |
26 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
4
|
1.5K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
2021.... Year of the boom ?
|
|
DeputyDawg
|
346 |
109K |
7 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
346
|
109K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
DeputyDawg
|
17K |
6.6M |
16 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
17K
|
6.6M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
DeputyDawg
|
1.6K |
461K |
29 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
1.6K
|
461K
|
29
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
DeputyDawg
|
10K |
3.0M |
5 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
DeputyDawg
|
17K |
6.6M |
15 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
17K
|
6.6M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
DeputyDawg
|
422 |
143K |
72 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
422
|
143K
|
72
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
DeputyDawg
|
508 |
170K |
15 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
170K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
DeputyDawg
|
508 |
170K |
45 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
170K
|
45
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
DeputyDawg
|
255 |
83K |
8 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
255
|
83K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
DeputyDawg
|
10K |
3.0M |
4 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Do you still think Mesoblast will be the next CSL?
|
|
DeputyDawg
|
155 |
66K |
93 |
29/12/20 |
29/12/20 |
ASX - By Stock
|
155
|
66K
|
93
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
DeputyDawg
|
317 |
155K |
15 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
317
|
155K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
DeputyDawg
|
796 |
393K |
25 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
393K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
DeputyDawg
|
192 |
86K |
5 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
192
|
86K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
DeputyDawg
|
13K |
4.9M |
16 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment
|
|
DeputyDawg
|
272 |
108K |
7 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
272
|
108K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
DeputyDawg
|
572 |
250K |
2 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
250K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
DeputyDawg
|
13K |
4.9M |
18 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
DeputyDawg
|
576 |
232K |
9 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
576
|
232K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Elli Lilly and now Regeneron not treating advanced COIVD-19 sufferers
|
|
DeputyDawg
|
25 |
11K |
18 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
25
|
11K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Elli Lilly and now Regeneron not treating advanced COIVD-19 sufferers
|
|
DeputyDawg
|
25 |
11K |
0 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
25
|
11K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
DeputyDawg
|
13K |
4.9M |
21 |
25/10/20 |
25/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
DeputyDawg
|
344 |
179K |
53 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
344
|
179K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
Tracking Valuations
|
|
DeputyDawg
|
322 |
169K |
7 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
322
|
169K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
DeputyDawg
|
53 |
25K |
27 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
53
|
25K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
DeputyDawg
|
31 |
13K |
7 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
31
|
13K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
DeputyDawg
|
518 |
262K |
29 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
518
|
262K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
DeputyDawg
|
13K |
4.9M |
15 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
4.9M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
DeputyDawg
|
854 |
426K |
4 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
854
|
426K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
DeputyDawg
|
23K |
13M |
4 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
DeputyDawg
|
23K |
13M |
39 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
23K
|
13M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
DeputyDawg
|
182 |
67K |
31 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
182
|
67K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
DeputyDawg
|
1.0K |
487K |
9 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
1.0K
|
487K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Capital raising
|
|
DeputyDawg
|
197 |
71K |
12 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
197
|
71K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
DeputyDawg
|
933 |
432K |
12 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
933
|
432K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Grunenthal and MSB Enter Strategic Partnership for Back Pain
|
|
DeputyDawg
|
162 |
84K |
12 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
162
|
84K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
DeputyDawg
|
274 |
110K |
8 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
274
|
110K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
DeputyDawg
|
23K |
13M |
6 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
DeputyDawg
|
847 |
333K |
9 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
847
|
333K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
DeputyDawg
|
17K |
6.6M |
18 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
17K
|
6.6M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
DeputyDawg
|
17K |
6.6M |
8 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
17K
|
6.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
More opportunities for Mesoblast
|
|
DeputyDawg
|
11 |
10K |
18 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
11
|
10K
|
18
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
DeputyDawg
|
23K |
13M |
23 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
23K
|
13M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
I'm Confused
|
|
DeputyDawg
|
17 |
5.9K |
6 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
17
|
5.9K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
The case for Mesoblast's MSCs for ARDS
|
|
DeputyDawg
|
221 |
88K |
15 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
221
|
88K
|
15
|
|